ESC 2020: Commentary on the EXPLORER-HCM Study

Published: 25 Sep 2020

  • Views:

    Views Icon 136
  • Likes:

    Heart Icon 0

Dr Giuseppe Galati (San Raffaele Scientific Institute, Milan, IT) comments on the Hot Line trial, EXPLORER-HCM. The trial measured the efficacy and safety of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.

Recorded remotely from Milan, 2020. 

Recording Editor: Natascha Wienand
Editor: Mirjam Boros